DaVita
DVA
$147.12
Share price
-0.01%
Change (1 day)
55.34%
Change (1 year)
Categories
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.
P/S ratio for DaVita (DVA)
P/S ratio as of June 2024 (TTM): 1.05
According to DaVita's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.04592. At the end of 2023 the company had a P/S ratio of 0.7883.
P/S ratio history for DaVita from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.7883 | 36.03% |
| 2022 | 0.5795 | -41.92% |
| 2021 | 0.9977 | -12.36% |
| 2020 | 1.14 | 37.3% |
| 2019 | 0.8291 | 10.43% |
| 2018 | 0.7508 | -38.34% |
| 2017 | 1.22 | 31.9% |
| 2016 | 0.9231 | -12.99% |
| 2015 | 1.06 | -16.88% |
| 2014 | 1.28 | 11.17% |
| 2013 | 1.15 | -19.89% |
| 2012 | 1.43 | 38.39% |
| 2011 | 1.04 | 0.07% |
| 2010 | 1.04 | 4.44% |
| 2009 | 0.9910 | 9.02% |
| 2008 | 0.9090 | -20.73% |
| 2007 | 1.15 | -5.96% |
| 2006 | 1.22 | -31.99% |
| 2005 | 1.79 | 5.79% |
| 2004 | 1.70 | 37.89% |
| 2003 | 1.23 | 51.61% |
| 2002 | 0.8108 | -35.37% |
| 2001 | 1.25 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Universal Health Services
UHS | 0.8229 | -21.32% | 🇺🇸 USA |
 LabCorp LH | 1.33 | 26.74% | 🇺🇸 USA |
 Tenet Healthcare THC | 0.6226 | -40.48% | 🇺🇸 USA |
 Pediatrix Medical Group MD | 0.3099 | -70.37% | 🇺🇸 USA |